Incannex Healthcare (IXHL) Cash from Financing Activities (2023 - 2026)

Incannex Healthcare has disclosed Cash from Financing Activities across 4 years of filings, most recently posting $4.7 million for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at $4.7 million, down 39.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $82.4 million (up 600.7% YoY), and the FY2025 annual result was $21.4 million, changed N/A from the prior year.
• Cash from Financing Activities came in at $4.7 million for Q1 2026 at Incannex Healthcare, up from $927000.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $67.2 million in Q3 2025 to a low of -$73000.0 in Q1 2023.
• The 4-year median for Cash from Financing Activities is $4.1 million (2024), against an average of $10.5 million.
• Peak annual rise in Cash from Financing Activities reached 129286.54% in 2025, while the deepest fall reached 77.4% in 2025.
• Incannex Healthcare's Cash from Financing Activities stood at -$32000.0 in 2023, then surged by 12918.75% to $4.1 million in 2024, then slumped by 77.4% to $927000.0 in 2025, then soared by 408.09% to $4.7 million in 2026.
• The last three Cash from Financing Activities figures came in at $4.7 million (Q1 2026), $927000.0 (Q4 2025), and $67.2 million (Q3 2025), per Business Quant data.